COVID-19 and Women's Health
As a result of the Coronavirus disease (COVID-19) pandemic, the world is facing one of the greatest challenges we have experienced in over a century. The economic consequences for society at large are potentially catastrophic. The health and social care sectors have reacted by providing emergency care on an unprecedented scale, while the scientific community has focused on developing new treatments and a vaccine to prevent future waves of the pandemic.
Evidence is emerging to suggest that certain conditions, such as obesity and hypertension, predispose some individuals to a worse outcome if they become infected, and that women may be less likely to die from COVID-19 than men. It is also currently believed that pregnant women are at no greater risk than the general population. There is an urgent need to determine whether these early observations are correct. Furthermore, we need to be sure that pregnancy outcomes are not affected by COVID-19 and that SARS-CoV-2 is not transmitted to the fetus during pregnancy or labour, nor to the infant through breast milk. There are so many questions that need to be answered to optimise care, avoid harm, reduce anxiety amongst women and their families, and inform health professionals and policymakers.
A standard EDITORIAL TRACKING SYSTEM is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing. Manuscripts can be uploaded online at Editorial Tracking System (https://www.imedpub.com/submissions/biology-medical-research.html) or forwarded to the Editorial Office at firstname.lastname@example.org
Journal of Biology and Medical Research
For Queries Contact: +1-504-608-2390